In rats that can't control glutamate, cocaine is less rewarding, staving off relapse

July 11, 2017, Cell Press
This cartoon depicts how a single-point (mGluR2) gene mutation alters a rat's sensitivity to cocaine reward and the subsequent drug-taking and drug-seeking behavior. Credit: Zheng-Xiong Xi and Lauren Brick

Rats missing a neuroreceptor that controls the release of the neurotransmitter glutamate are less amenable to the rewarding effects of cocaine, increasing their chance of kicking the habit once addicted, researchers from the National Institute on Drug Abuse (NIDA) find. Their work, appearing July 11 in Cell Reports, suggests that the receptor, which protects nerve cells from fatal inundation by excess glutamate, is involved in modulating the reward-seeking behavior associated with drug addiction.

By silencing the gene responsible for expressing the receptor, called mGluR2, the researchers studied its effect across the stages of the cycle. Rats without the receptor were more likely to consume cocaine when it was made freely available but less likely to seek out cocaine when they had to demonstrate more effort to obtain it. When cocaine was no longer available to them, the rats were quicker to cease the behaviors that had previously resulted in the 's delivery. Even when cocaine was subsequently re-introduced, they showed reduced interest for drug seeking, constituting a lower rate of relapse.

"The gene-knockout mice don't enjoy much reward when they take the cocaine. So when the drug is available to them, the animals work to increase their intake to feel rewarded," says senior author Zheng-Xiong Xi, an researcher at NIDA. "But when the drug is difficult to get, the reward isn't worth it anymore, the animal just wants to quit."

This apparent incongruity between increased early cocaine use and decreased later relapse is resolved by a single explanation: low or absent mGluR2 expression causes the rodents to experience a lessened neurological reward when taking cocaine, as measured by intracranial probing of brain stimulation.

At the cellular level, the research illuminates the role that glutamate—the most abundant neurotransmitter in all vertebrates and a prominent contributor to pathways of learning, memory, and anxiety in humans—plays in cocaine addiction, going beyond previous findings that focused on dopamine response, more commonly associated with reward seeking, as the main culprit. Deleting mGluR2 causes nerve cells to be awash in glutamate before any cocaine is ingested. Since cocaine "works" by binding to receptors in place of neurotransmitters like glutamate and dopamine, forcing them to float around and excite synapses, the preexisting flood of limits its power to deliver a neurological reward.

In the long run, mGluR2's involvement in reward circuits could let it pack a double punch as a biomarker for predicting risk of cocaine addiction and as a therapeutic target for drug development. "Our work suggests that, if you could take a medicine to activate mGluR2 activity, then it would decrease or significantly inhibit both cocaine-taking and -seeking behaviors," Xi says.

The researchers also plan on studying the influence of mGluR2—which has been preliminarily associated with alcohol and nicotine addictions—in relation to opiates such as heroin. "It seems that mGluR2 may be a common target for treating addictions to many drugs," Xi says.

Explore further: Male rats found to pass on epigenetic susceptibility to cocaine addiction to offspring

More information: Cell Reports, Yang et al.: "Deletion of Type 2 Metabotropic Glutamate Receptor (mGluR2) Decreases Sensitivity to Cocaine Reward in Rats" http://www.cell.com/cell-reports/fulltext/S2211-1247(17)30860-4 , DOI: 10.1016/j.celrep.2017.06.046

Related Stories

Male rats found to pass on epigenetic susceptibility to cocaine addiction to offspring

May 31, 2017
(Medical Xpress)—A team of researchers with Fudan University in China has found that male rats are able to pass on their susceptibility to cocaine addiction through non-genetic means. In their paper published in the journal ...

Three new studies converge on promising new target for addiction treatment

September 14, 2015
The latest issue of Biological Psychiatry presents the results of three studies implicating metabotropic glutamate receptor 2 (mGluR2) as a new molecular target for the treatment of addiction.

Mouse studies offer new insights about cocaine's effect on the brain

February 15, 2017
Cocaine is one of the most addictive substances known to man, and for good reason: By acting on levels of the "feel-good" chemical dopamine, it produces a tremendous sensation of euphoria.

Treating cocaine addiction by reducing our appetite for drugs?

March 16, 2017
The hypocretin/orexin (HCRT) system of the brain is best known for promoting wakefulness and appetite. A new paper in Biological Psychiatry suggests that blocking hypocretin signaling via the HCRT-1 receptor (HCRT-R1) might ...

Brain area involved in addiction activated earlier than previously thought in recreational cocaine users

May 23, 2017
Even among non-dependent cocaine users, cues associated with consumption of the drug lead to dopamine release in an area of the brain thought to promote compulsive use, according to researchers at McGill University.

Recommended for you

Rare in-vivo study shows weak brain nodes have strong influence on memory network

June 20, 2018
Our ability to learn, remember, problem solve, and speak are all cognitive functions related to different parts of our brain. If researchers can identify how those brain parts communicate and exchange information with each ...

A dual-therapy approach to boost motor recovery after a stroke

June 20, 2018
Paralysis of an arm and/or leg is one of the most common effects of a stroke. But thanks to research carried out by scientists at the Defitech Foundation Chair in Brain-Machine Interface and collaborators, stroke victims ...

Powerful new approach helps understand molecular alterations in neurological disease

June 20, 2018
Neurological diseases are typically associated with a multitude of molecular changes. But out of these thousands of changes in gene expression, which ones are actually driving the disease? To answer this question, a team ...

Scientists unravel DNA code behind rare neurologic disease

June 20, 2018
Scientists conducting one of the largest full DNA analyses of a rare disease have identified a gene mutation associated with a perplexing brain condition that blinds and paralyzes patients.

New technique fine-tunes treatment for severe epilepsy cases

June 20, 2018
One of three epilepsy patients experience no relief from drugs and are candidates for surgery. An advance by researchers at Yale and the Cleveland Clinic will enable surgeons to more precisely target areas of the brain causing ...

Absence epilepsy—when the brain is like 'an orchestra without a conductor'

June 20, 2018
At first, the teacher described her six-year-old student as absentminded, a daydreamer. The boy was having difficulty paying attention in class. As the teacher watched the boy closely, she realized that he was not daydreaming. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.